How a biotech exec is leveraging Big Pharma lessons to advance tRNA

Michelle Werner is a powerhouse in biopharma, balancing the macro and micro environment and tackling venture capital along with the nitty gritty science.

She currently serves as a CEO-partner at Flagship Pioneering, a leading biotech venture capital company, and CEO of Alltrna, a preclinical biotech backed by the VC. But her previous experience boasts some of the biggest names in pharma, including roles at Bristol Myers Squibb, AstraZeneca and Novartis. After her entrance into the biotech startup space at Alltrna in 2022, Werner now finds herself at the forefront of development for a novel therapeutic modality using tRNA biology.